Srinivas Akkaraju - Insider Trading & Ownership

Location
565 Everett Avenue, Palo Alto, CA
Summary
The estimated net worth of Srinivas Akkaraju is at least $417M dollars as of October 7, 2025. Srinivas Akkaraju is the Director of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $218M. Srinivas Akkaraju is the Director of Mineralys Therapeutics, Inc. and owns shares of Mineralys Therapeutics, Inc. (MLYS) stock worth about $101M. Srinivas Akkaraju is the Director of vTv Therapeutics Inc. and owns shares of vTv Therapeutics Inc. (VTVT) stock worth about $76.4M. Srinivas Akkaraju is the Director of ALUMIS INC. and owns shares of ALUMIS INC. (ALMS) stock worth about $20.8M. Srinivas Akkaraju is the Director, 10%+ Owner of Kalaris Therapeutics, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $36.1K. Srinivas Akkaraju is the Director of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. (SYRS) stock worth about $20.1K.
Signature
/s/ Srinivas Akkaraju
All Insider Reports
All Insider Reports

Ownership of Srinivas Akkaraju

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRRK Scholar Rock Holding Corp Director $218M +$18.8M +9.44% Oct 3, 2025
MLYS Mineralys Therapeutics, Inc. Director $101M +$23.1M +29.5% Sep 4, 2025
VTVT vTv Therapeutics Inc. Director $76.4M Sep 22, 2025
ALMS ALUMIS INC. Director $20.8M +$1.48M +7.65% Jul 30, 2025
KLRS Kalaris Therapeutics, Inc. Director, 10%+ Owner $36.1K Apr 10, 2025
SYRS Syros Pharmaceuticals, Inc. Director $20.1K Sep 16, 2024
KDNY CHINOOK THERAPEUTICS, INC. Director Aug 11, 2023
ICPT INTERCEPT PHARMACEUTICALS, INC. Director Nov 8, 2023
JYAC Jiya Acquisition Corp. Director, 10%+ Owner Sep 23, 2022

Insider Transactions Reported by Srinivas Akkaraju:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.